Mirtazapine can reduce anxiety, and it often works faster than many people expect. In a large naturalistic study of nearly 4,800 patients, anxiety scores dropped by about 23% after just one week of treatment and roughly 50% after six weeks. That said, mirtazapine is not FDA-approved for any anxiety disorder. It’s approved for major depressive disorder, and any use for anxiety is considered off-label.
How Mirtazapine Reduces Anxiety
Mirtazapine works differently from SSRIs like sertraline or escitalopram. Rather than blocking serotonin from being reabsorbed, it increases the release of both serotonin and norepinephrine by blocking a specific receptor that normally keeps those chemicals in check. It then selectively channels serotonin toward the receptors associated with mood and anxiety relief while blocking the receptors linked to nausea, agitation, and sexual side effects.
It also strongly blocks histamine receptors, which produces a calming, sedative effect. This is a big part of why mirtazapine can feel like it “takes the edge off” anxiety quickly, sometimes within the first few days. The sedation is most pronounced at lower doses. At higher doses, the increased norepinephrine activity partially counteracts the drowsiness, so people on lower doses (around 15 mg) often feel more sedated than those on 30 or 45 mg.
What the Evidence Shows for Different Anxiety Types
The strongest case for mirtazapine and anxiety comes from patients who have depression alongside significant anxiety symptoms. The rapid drop in anxiety scores seen in clinical practice, roughly 40% improvement at two weeks, comes from this population. For people whose anxiety is tangled up with depression, insomnia, or poor appetite, mirtazapine can address several problems at once.
For standalone anxiety disorders, the picture is less clear. A randomized, double-blind trial tested mirtazapine (30 to 45 mg per day) against placebo in 60 patients with generalized social anxiety disorder over 12 weeks. The result: mirtazapine failed to separate from placebo. Only 13% of patients in each group met the threshold for treatment response. That’s a notably poor showing, and it suggests mirtazapine is not a reliable choice for social anxiety on its own.
Evidence for panic disorder and generalized anxiety disorder as standalone conditions is limited and mostly based on small studies or case series rather than robust trials. Clinicians sometimes prescribe it for these conditions, but it’s typically not a first-line option.
Why It’s Often Prescribed After SSRIs
Mirtazapine is usually tried after SSRIs haven’t worked well enough or have caused intolerable side effects. SSRIs are the standard first-line treatment for most anxiety disorders because they have the deepest evidence base. Mirtazapine tends to come into play when someone has had trouble with SSRI-related sexual dysfunction, nausea, or insomnia, since mirtazapine is less likely to cause those particular problems.
It’s also sometimes added to an SSRI rather than used as a replacement. The combination boosts serotonin and norepinephrine through two different mechanisms, which can help people who’ve had a partial response to an SSRI alone. This combination does carry a theoretical risk of serotonin syndrome, a rare but serious reaction caused by excess serotonin activity, so it requires careful monitoring.
The Sedation and Sleep Factor
For people whose anxiety is worst at night, driving insomnia and racing thoughts at bedtime, mirtazapine’s sedative quality can be genuinely useful. It’s taken at bedtime, and many people notice improved sleep within the first few nights. This alone can break a cycle where poor sleep feeds daytime anxiety, which feeds poor sleep.
The sedation does tend to lessen over the first couple of weeks as your body adjusts. Some people find the morning grogginess manageable, while others find it disruptive, especially at the start. If daytime drowsiness is a concern, it’s worth knowing that it’s usually strongest in the first week or two and often improves.
Weight Gain and Other Side Effects
Weight gain is the side effect people worry about most with mirtazapine, and it’s a legitimate concern. In one clinical study, patients gained an average of 3 kg (about 6.6 pounds) during treatment, with the increase coming primarily from added fat mass rather than water retention. Mirtazapine increases appetite, particularly cravings for carbohydrates, which drives the weight change.
One reassuring finding: unlike some psychiatric medications that cause weight gain and also worsen blood sugar or cholesterol, mirtazapine did not affect insulin sensitivity, glucose levels, or lipid profiles in that same study. The weight gain is real, but it doesn’t appear to come packaged with the metabolic disruption seen with certain other medications.
Other common side effects include dry mouth, increased appetite independent of weight gain, and dizziness. Notably, mirtazapine causes far less sexual dysfunction, nausea, and restlessness than SSRIs. For someone who quit an SSRI because of those side effects, that tradeoff can be worthwhile.
How Quickly It Works
One of mirtazapine’s advantages is its relatively fast onset. The sedative and calming effects can kick in within the first few days. Measurable anxiety reduction, based on the large multicenter study, follows a clear trajectory: about 23% improvement at one week, 40% at two weeks, and 50% or more by six weeks. That first-week improvement is faster than what most SSRIs deliver, where meaningful anxiety relief typically takes two to four weeks to begin.
Full antidepressant effects, if you’re also being treated for depression, generally take four to six weeks to develop. So the anxiety relief and sleep improvement often arrive well before the mood benefits fully stabilize.
Who Benefits Most
Mirtazapine tends to be a good fit for a specific profile: someone with anxiety accompanied by depression, insomnia, poor appetite, or nausea. Its ability to improve sleep, stimulate appetite, and calm anxiety simultaneously makes it unusually versatile for people dealing with that cluster of symptoms. It’s less well suited as a standalone treatment for a primary anxiety disorder like social anxiety or panic disorder, where SSRIs and certain other medications have stronger evidence behind them.
If you’re underweight or struggling to eat because of anxiety or depression, the appetite-stimulating effect that others consider a drawback may actually be a benefit. Context matters with this medication more than most.